Personalized Biomarker-Based Therapy for GE Carcinoma: Tumoral Heterogeneity, OS Data for 1L FOLFOX6 + 2L FOLFIRI + 3L FOLFTAX for Metastatic Disease

25 views
June 11, 2021
Comments 0
Login to view comments. Click here to Login